Literature DB >> 29531945

Astrocyte elevated gene-1 (AEG-1): a new potential therapeutic target for the treatment of nonalcoholic steatohepatitis (NASH).

Qinglan Wang1,2, Ekihiro Seki1,3,4,5.   

Abstract

Entities:  

Year:  2018        PMID： 29531945      PMCID： PMC5835612          DOI： 10.21037/hbsn.2017.11.04

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  8 in total

1.  Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  A Lonardo; C D Byrne; S H Caldwell; H Cortez-Pinto; G Targher
Journal:  Hepatology       Date:  2016-05-24       Impact factor: 17.425

2.  Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.

Authors:  Jyoti Srivastava; Ayesha Siddiq; Luni Emdad; Prasanna Kumar Santhekadur; Dong Chen; Rachel Gredler; Xue-Ning Shen; Chadia L Robertson; Catherine I Dumur; Phillip B Hylemon; Nitai D Mukhopadhyay; Deepak Bhere; Khalid Shah; Rushdy Ahmad; Shah Giashuddin; Jillian Stafflinger; Mark A Subler; Jolene J Windle; Paul B Fisher; Devanand Sarkar
Journal:  Hepatology       Date:  2012-11       Impact factor: 17.425

3.  Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).

Authors:  Devaraja Rajasekaran; Jyoti Srivastava; Kareem Ebeid; Rachel Gredler; Maaged Akiel; Nidhi Jariwala; Chadia L Robertson; Xue-Ning Shen; Ayesha Siddiq; Paul B Fisher; Aliasger K Salem; Devanand Sarkar
Journal:  Bioconjug Chem       Date:  2015-06-25       Impact factor: 4.774

Review 4.  Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology.

Authors:  Byoung Kwon Yoo; Luni Emdad; Seok-Geun Lee; Zao-zhong Su; Prasanna Santhekadur; Dong Chen; Rachel Gredler; Paul B Fisher; Devanand Sarkar
Journal:  Pharmacol Ther       Date:  2011-01-20       Impact factor: 12.310

Review 5.  Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.

Authors:  G Chinetti; J C Fruchart; B Staels
Journal:  Inflamm Res       Date:  2000-10       Impact factor: 4.575

6.  Nonalcoholic fatty liver disease in Asia: a story of growth.

Authors:  Vincent Wai-Sun Wong
Journal:  J Gastroenterol Hepatol       Date:  2013-01       Impact factor: 4.029

7.  A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH).

Authors:  Jyoti Srivastava; Chadia L Robertson; Kareem Ebeid; Mikhail Dozmorov; Devaraja Rajasekaran; Rachel Mendoza; Ayesha Siddiq; Maaged A Akiel; Nidhi Jariwala; Xue-Ning Shen; Jolene J Windle; Mark A Subler; Nitai D Mukhopadhyay; Shah Giashuddin; Shobha Ghosh; Zhao Lai; Yidong Chen; Paul B Fisher; Aliasger K Salem; Arun J Sanyal; Devanand Sarkar
Journal:  Hepatology       Date:  2017-06-30       Impact factor: 17.425

8.  First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement.

Authors:  Josep Tabernero; Geoffrey I Shapiro; Patricia M LoRusso; Andres Cervantes; Gary K Schwartz; Glen J Weiss; Luis Paz-Ares; Daniel C Cho; Jeffrey R Infante; Maria Alsina; Mrinal M Gounder; Rick Falzone; Jamie Harrop; Amy C Seila White; Iva Toudjarska; David Bumcrot; Rachel E Meyers; Gregory Hinkle; Nenad Svrzikapa; Renta M Hutabarat; Valerie A Clausen; Jeffrey Cehelsky; Saraswathy V Nochur; Christina Gamba-Vitalo; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Howard A Burris
Journal:  Cancer Discov       Date:  2013-01-28       Impact factor: 39.397
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.